Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001955775 | SCV002222538 | uncertain significance | not provided | 2024-08-03 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 33 of the C1QB protein (p.Gly33Arg). This variant is present in population databases (rs764348361, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with C1QB-related conditions. ClinVar contains an entry for this variant (Variation ID: 1443928). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Possibly Damaging". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mayo Clinic Laboratories, |
RCV001955775 | SCV005410400 | uncertain significance | not provided | 2024-05-08 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005006288 | SCV005639897 | uncertain significance | C1Q deficiency 2 | 2024-03-25 | criteria provided, single submitter | clinical testing |